Oligomannose sugars on gp120 are of significance to HIV vaccine design because of the description of the broadly neutralizing mAb 2G12 and, more recently, of the potent and broadly neutralizing ‘PGT’ series of mAbs, which bind with high affinity to clusters of oligomannose moieties on gp120. Attempts to elicit oligomannose-specific antibodies have focused mainly on immunizing with antigenic clusters of synthetic oligomannose or natural oligomannose. These strategies have had limited success, suggesting that alternative approaches are needed. Here, we present the surface lipo-oligosaccharide (LOS) of Rhizobium radiobacter Rv3 that antigenically mimics the 2G12 epitope, as one potential new avenue of exploration
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Oligomannose sugars on gp120 are of significance to HIV vaccine design because of the description of...
Oligomannose sugars on gp120 are of significance to HIV vaccine design because of the description of...
SummaryThe broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugar...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
SummaryThe broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugar...
Lipooligosaccharides (LOS) from the bacterium Rhizobium radiobacter Rv3 are structurally related to ...
AbstractHuman antibody 2G12 broadly neutralizes human immunodeficiency virus type 1 (HIV-1) isolates...
Human immunodeficiency virus-1 (HIV-1) is a major public health threat that continues to infect mill...
Human immunodeficiency virus-1 (HIV-1) is a major public health threat that continues to infect mill...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Oligomannose sugars on gp120 are of significance to HIV vaccine design because of the description of...
Oligomannose sugars on gp120 are of significance to HIV vaccine design because of the description of...
SummaryThe broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugar...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
The broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugars on t...
SummaryThe broadly neutralizing antibody 2G12 binds a fairly conserved cluster of oligomannose sugar...
Lipooligosaccharides (LOS) from the bacterium Rhizobium radiobacter Rv3 are structurally related to ...
AbstractHuman antibody 2G12 broadly neutralizes human immunodeficiency virus type 1 (HIV-1) isolates...
Human immunodeficiency virus-1 (HIV-1) is a major public health threat that continues to infect mill...
Human immunodeficiency virus-1 (HIV-1) is a major public health threat that continues to infect mill...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...
Immunologically, "self" carbohydrates protect the HIV-1 surface glycoprotein, gp120, from antibody r...